BioPharmSignal logoBioPharmSignal

Biotech News

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MiMedx (MDXG)MiMedxCompany update

Multispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its

Related news

MDXGMiMedx2026-09-08 12:00 EST

MIMEDX to Participate in Upcoming Investor Conferences

MDXGMiMedx2026-02-04 15:28 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

STTKShattuck Labs2026-09-02 20:05 EST

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

CHRSCoherus BioSciences, Inc.2026-08-31 13:30 EST

Coherus to Participate in Upcoming Investor Conferences

STTKShattuck Labs2026-02-25 13:00 EST

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

CHRSCoherus BioSciences, Inc.2026-02-23 14:30 EST

Coherus Oncology to Participate in Upcoming Investor Conferences

RXRXRecursion2026-06-02 12:00 EST

Recursion to Participate in Upcoming Investor Conferences

ENTXEntera Bio2026-08-27 13:44 EST

Correction: Entera to Participate in Upcoming Fall Investor Conferences

ALVOAlvotech2026-08-27 12:00 EST

Alvotech to present at upcoming investor conferences in September

ENTXEntera Bio2026-08-27 12:00 EST

Entera to Participate in Upcoming Fall Investor Conferences

View all latest news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

MDXGMiMedx2026-09-23 20:01 EST

MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

MDXGMiMedx2026-09-08 12:00 EST

MIMEDX to Participate in Upcoming Investor Conferences

MDXGMiMedx2026-07-29 20:07 EST

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MDXGMiMedx2026-07-29 20:01 EST

MIMEDX to Acquire Sanara MedTech

MDXGMiMedx2026-07-20 12:00 EST

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

Stock data

Close
4.62 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States